Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Guidance
03 mars 2023 07h00 HE
|
Rapid Micro Biosystems, Inc.
Reports fourth quarter 2022 commercial revenue of $4.4 million Reports full year 2022 commercial revenue of $17.1 million Delivered full year 2022 recurring commercial revenue of $11.0 million,...
Rapid Micro Biosystems to Participate in the Cowen 43rd Annual Health Care Conference
28 févr. 2023 16h52 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023
16 févr. 2023 16h05 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Revenue
11 janv. 2023 09h00 HE
|
Rapid Micro Biosystems, Inc.
Full year 2022 commercial revenue expected to be between $17.0 million and $17.2 million Finished 2022 with approximately $140 million in cash and investments providing runway at least into 2026 ...
Rapid Micro Biosystems to Present at 41st Annual J.P. Morgan Healthcare Conference
05 janv. 2023 08h00 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports Third Quarter 2022 Financial Results
10 nov. 2022 07h00 HE
|
Rapid Micro Biosystems, Inc.
Reports third quarter 2022 commercial revenue of $4.7 million Delivered year-over-year recurring revenue growth of 34% Reaffirms full year 2022 commercial revenue guidance of at least $17.0 million ...
Rapid Micro Biosystems to Announce Third Quarter 2022 Financial Results on November 10, 2022
02 nov. 2022 08h00 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Announces RMBNucleus™ Mold Alarm for the Growth Direct® System
10 oct. 2022 08h30 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Exhibit at the 2022 PDA Pharmaceutical Microbiology Conference
04 oct. 2022 08h30 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems CEO Rob Spignesi to Speak at the 2022 PDA/FDA Joint Regulatory Conference
12 sept. 2022 09h00 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...